ArticleVeterinary research communications2026
Effects of bovine lactoferrin on the growth and biofilm formation of Escherichia coli and Klebsiella pneumoniae associated with bovine mastitis.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Escherichia coli and Klebsiella pneumoniae are major causal pathogens of mastitis in dairy cows. In this study, we focus on bovine lactoferrin, an endogenous protein with antimicrobial and antibiofilm activities expressed in mammary glands. Given that the activity of lactoferrin against bovine mastitis-associated pathogens has yet to be fully elucidated, we sought to determine its effects on the growth and biofilm formation of E. coli and K. pneumoniae. We selected 24 and 20 isolates of E. coli and K. pneumoniae, respectively, including mastitis- and environmentally derived isolates, and examined the antimicrobial and antibiofilm effects of lactoferrin using a microdilution method and crystal violet staining, respectively. The percentages of E. coli and K. pneumoniae isolates for which we obtained lactoferrin minimum inhibitory concentration ≥ 4,000 µg/mL were 57% and 80%, respectively. At concentrations of 200 and 1,000 µg/mL, although lactoferrin caused significant reductions in the growth of both E. coli and K. pneumoniae, whereas biofilm formation by K. pneumoniae was inhibited, that of E. coli was paradoxically enhanced. These findings highlight that E. coli and K. pneumoniae, which have traditionally been grouped as coliforms in the context of bovine mastitis, have distinct responses when exposed to lactoferrin.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.